odine, preferably fluorine or chlorine. [0045] Preferred compounds are compounds of formula I wherein X1 and X2 are CH. [0046] A further embodiment of the invention is a pharmaceutical composition containing as an active ingredient a compound of formula I [0047] or a pharmaceutically acceptable salt or prodrug thereof, [0048] wherein [0049] X1 and X2 are each independently selected from a CH group